HappeningToo topic
Erenumab-aooe reports
Browse community reports connected to Erenumab-aooe. These reports can show that other people are describing similar experiences, but they do not prove that Erenumab-aooe caused a symptom or reaction.
⚕️ Medicine safety note
Community reports do not prove causation, cannot be used to estimate how common a reaction is, and are not medical advice.
26 problems
Abdominal Discomfort while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and abdominal discomfort appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Abdominal Pain Upper while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and abdominal pain upper appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Acid reflux while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and acid reflux appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Alopecia while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and alopecia appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Constipation while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and constipation appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Diarrhea while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and diarrhea appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dizziness while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and dizziness appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dry Mouth while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and dry mouth appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Dyspepsia while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and dyspepsia appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Fatigue while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and fatigue appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Headache while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and headache appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Hives while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and hives appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Insomnia while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and insomnia appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Malaise while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and malaise appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Migraine while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and migraine appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Muscle Spasms while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and muscle spasms appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Nausea while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and nausea appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Neck Pain while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and neck pain appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Pain while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and pain appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Rash while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and rash appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Shortness of breath while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and shortness of breath appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Swelling while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and swelling appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Tingling or pins and needles while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and tingling or pins and needles appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Vomiting while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and vomiting appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weakness while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and weakness appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →
Weight Increased while using Erenumab-aooe
FDA FAERS contains adverse-event reports in which Erenumab-aooe and weight increased appear together. This does not establish that Erenumab-aooe caused the reported reaction and cannot be used to estimate how often it occurs.
View reports →